Salim Yusuf is a Professor of Medicine and Clinical Epidemiology and Biostatistics at McMaster University and Director of the Population Health Research Institute. As a Rhodes Scholar, he initiated the concept of large simple trials, coordinating the first ISIS trial and developing concepts of meta-analysis. Subsequently, he has applied these principles to several other areas that led to the SOLVD and DIG trials in heart failure while at the US NIH, and more recently the HOPE, OASIS, CURE and CREATE trials since his move to McMaster University, Canada. He holds a Heart and Stroke Foundation ...

Professor Emeritus, University of Alberta

Kue Young has played a pivotal role in the development of Aboriginal and northern health research in Canada and internationally. He was one of the first researchers in Canada to recognize the emerging diabetes epidemic among First Nations in the early 1980’s. He has contributed substantially to understanding the epidemiology and genetics of diabetes in that population, and its prevention and control. A population health research scientist of the first order, he received the CIHR Senior Investigator award 1998-2008. Dr. Young has authored six books on Aboriginal and circumpolar health, and a ...

Vice Dean, Education, University of British Columbia

Dr. Roger Wong is a Clinical Professor and the Vice Dean, Education in the UBC Faculty ofMedicine.Dr. Wong has been appointed to the Order of Canada, the first time a geriatrician is appointed to the country's highest civilian honour, for his contributions to the field of geriatric medicine, including the advancement of policies, education and specialized, culturally sensitive health care.Dr. Wong has received a number of prestigious awards in recognition of his exceptional national leadership in the field of seniors’ health care, including the Ronald Cape Distinguished Service Award, which ...

Dr. James Wright is a global leader in surgeryand has made important contributions to the care of Children. He was the first orthopedic surgeon to gain advanced clinical research training in north America and is a leader in applying evidence in orthopedics, which is transforming thecare of patients Worldwide. Nationally, his efforts have led to shortened surgical wait times for children. As Surgeon-in- Chief and Medical VP at Sickkids, one of the world's premier children's hospitals, his leadership has led to a culture of safety and innovation. He has received the highest research awards of ...

Ron Worton retired in 2007 from the position of CEO and Scientific Director of the Ottawa Hospital Research Institute, Vice President of Research at the Ottawa Hospital and Professor at the University of Ottawa. He previously served as Geneticist-in-Chief at the Hospital for Sick Children and as the inaugural Scientific Director of the Stem Cell Network. Dr. Worton has served on the boards of many organizations, including the Canadian College of Medical Geneticists, the International Human Genome Organization, Genome Canada, Research Canada (two years as Chair) and the American Society of ...

Senior Scientist, University Health Network

Prof. Tymianski is a Senior Scientist at the Krembil Brain Institute. Among his scientific contributions is the discovery and development of PSD95 inhibitors for the treatment of stroke and related neurological disorders. His research spans from protein chemistry to global clinical trials. A lead compound, nerinetide, has completed Phase 3 trials and continues to be developed. Next generation compounds are also entering clinical studies. He is a retired neurosurgeon, having treated patients with complex cerebrovascular disorders, and leads NoNO Inc., a biotechnology company that sponsors the ...

Professor, University of Alberta

Lorne Tyrrell is a Professor of Medical Microbiology and Immunology at the University of Alberta and served for 10 years as Dean of the Faculty of Medicine and Dentistry until 2004. He currently holds the ClHR/GSK Chair in Virology at the University of Alberta. In 1986, with Dr. Morris Robins, he began working on a system to identify potent antivirals against hepatitis B virus (HBV) which infects about 400 million people worldwide. Through their work they discovered several potent antivirals against HBV and this resulted in a major collaboration with Glaxo Canada (now GlaxoSmithKline). The ...

Professor & Head, Neurology, University of British Columbia

Dr. A. Jon Stoessl, Professor of Neurology and Director of the Pacific Parkinson’s Research Centre is a world leader in research and clinical activities pertaining to Positron Emission Tomography and movement disorders, including Parkinson’s Disease. He is a pioneer in these fields and provided the first evidence of the placebo effect in Parkinson’s disease is mediated by the release of substantial levels of dopamine in the brain. He is also involved in international collaborations that have led to the discovery of new gene mutations that result in Parkinson-like disorders.

University Professor, University of Toronto

Donald Stuss is President and Scientific Director of the Ontario Brain Institute (2011-); University Professor of Medicine (Neurology/Rehab Sci) and Psychology at the University of Toronto; founding director of The Rotman Research Institute at Baycrest (1989-2008). Dr. Stuss has authored over 190 peer-reviewed publications and 48 book chapters. His honours include the Order of Ontario (2001), University of Toronto Faculty Award (2004), Fellow of the Royal Society of Canada, election to University Professor status at the University of Toronto; and National Academy of Neuropsychology 2011 ...

Professor, Dept. of Philosophy, Dalhousie University

Susan Sherwin holds a Dalhousie University Research Professorship and has served as Chair of the university’s Department of Philosophy. She has straddled the divide between moral philosophy and bioethics for some time. Internationally, she is considered one of the world’s foremost feminist ethicists and she serves on committees for numerous organizations such as the Royal College where she serves on the Ethics and Equity Committee; CIHR as a member of the Standing Committee on Ethics; UNESCO; CIAR; and Health Canada on the Advisory Group on Reproductive and Genetic Technologies. Dr. Sherwin ...